| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 82 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Obese |
900mg (3x300mg) Benfotiamine daily for 12 weeks in diabetics with moderate-high levels of urinary albumin failed to reduce serum or urinary AGEs in a trial where diet was not controlled.
